Minimally invasive liver resection for colorectal metastasis is safe, feasible, and oncologically comparable to open liver resection for both minor and major liver resections, even with prior intra-abdominal operations, in selected patients and when performed by experienced surgeons.
Background
Describe the outcomes and safety of robotic‐assisted kidney auto‐transplantation (RAKAT) in the treatment of nutcracker syndrome (NCS) and loin pain haematuria syndrome (LPHS).
Methods
This retrospective study included 32 cases of NCS and LPHS seen during December 2016 to June 2021.
Results
Three (9%) patients had LPHS and 29 (91%) NCS. All were non‐Hispanic whites, and 31 (97%) women. The mean age was 32 years (SD = 10) and the BMI 22.8 (SD = 5). The RAKAT was completed in all patients, 63% had a total improvement of pain. According to the Clavien‐Dindo classification, 47% presented with type 1, and 9% with type 3 complications with a mean follow‐up of 10.9 months. The incidence of acute kidney injury in post‐procedure was 28%. No one required blood transfusions, and there were no deaths during the follow‐up.
Conclusion
RAKAT was a feasible procedure with a similar complication rate to those reported for other surgical techniques.
The workup algorithm, which primarily uses duration of renal failure, glofil measurement, and renal biopsy findings, offers a practical approach to this complicated decision-making process regarding appropriate allocation of organs for CLKT.
Several characteristics may prove useful for selecting patients likely to respond well to Y-90 resin. These results should be confirmed in prospective studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.